Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap | 33.87M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | 5.08M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -11.00% |
Sales | 23.36M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -16.00% |
Dividend | N/A | Price/Book | 1.45 | EPS next 5Y | - | 52W High Chg | -43.00% |
Recommedations | - | Quick Ratio | 4.67 | Shares Outstanding | 136.70M | 52W Low Chg | 8.00% |
Insider Own | 14.55% | ROA | 3.82% | Shares Float | 115.55M | Beta | 0.37 |
Inst Own | 0.43% | ROE | 20.04% | Shares Shorted/Prior | -/- | Price | 0.25 |
Gross Margin | 57.21% | Profit Margin | 21.73% | Avg. Volume | 8,522 | Target Price | - |
Oper. Margin | 3.27% | Earnings Date | Dec 19 | Volume | 7,250 | Change | 0.00% |
About MICROBIX BIOSYSTEMS
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
MICROBIX BIOSYSTEMS News